We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+14.84%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$65.3B
AUM Growth
+$7.1B
(+12%)
Cap. Flow
-$1.98B
Cap. Flow
% of AUM
-3.04%
Top 10 Holdings %
Top 10 Hldgs %
42.82%
Holding
1,073
New
165
Increased
251
Reduced
511
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
O'Reilly Automotive
ORLY
|
+$103M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$88M |
| 3 |
Mettler-Toledo International
MTD
|
+$61.2M |
| 4 |
Illumina
ILMN
|
+$49.4M |
| 5 |
S&P Global
SPGI
|
+$36.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$766M |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$284M |
| 3 |
Meta Platforms (Facebook)
META
|
+$205M |
| 4 |
Zions Bancorporation
ZION
|
+$86.6M |
| 5 |
Accenture
ACN
|
+$60.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.98% |
| 2 | Communication Services | 16.8% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Healthcare | 13.27% |
| 5 | Financials | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
HealthEquity
HQY
$8.75B
| $58.4M | 0.09% |
880,654
+480,971
| +120% | +$33.3M |
|
102
Applied Industrial Technologies
AIT
$13.3B
| $58.3M | 0.09% |
337,730
-10,691
| -3% | -$1.73M |
|
103
Evertec
EVTC
$1.78B
| $57.6M | 0.09% |
1,407,524
-44,526
| -3% | -$1.64M |
|
104
Kratos Defense & Security Solutions
KTOS
$11.4B
| $57.1M | 0.09% |
2,812,119
+352,934
| +14% | +$6.49M |
|
105
United Therapeutics
UTHR
$23.1B
| $55.9M | 0.09% |
254,044
-11,255
| -4% | -$2.59M |
|
106
Ambev
ABEV
$46.4B
| $55.3M | 0.08% |
19,756,428
-376,619
| -2% | -$1.02M |
|
107
Procept Biorobotics
PRCT
$1.17B
| $55.2M | 0.08% |
1,316,708
-28,746
| -2% | -$979K |
|
108
PJT Partners
PJT
$4.38B
| $55.1M | 0.08% |
541,009
-17,128
| -3% | -$1.47M |
|
|
CWAN
109
DELISTED
Clearwater Analytics
CWAN
| $54.8M | 0.08% |
2,735,902
+1,727,326
| +171% | +$34M |
|
110
Veeva Systems
VEEV
$37.4B
| $54.7M | 0.08% |
283,934
+35,616
| +14% | +$6.71M |
|
111
Onto Innovation
ONTO
$15.3B
| $54.2M | 0.08% |
354,784
+19,494
| +6% | +$2.62M |
|
|
112
Bank of America Series L
BAC.PRL
$3.99B
| $51.4M | 0.08% |
1,525,880
-685,460
| -31% | -$766M |
|
113
Medpace
MEDP
$16.5B
| $50.2M | 0.08% |
163,874
+1,345
| +0.8% | +$363K |
|
|
CHX
114
DELISTED
ChampionX
CHX
| $49.9M | 0.08% |
1,708,020
-411,851
| -19% | -$12.7M |
|
115
Kinsale Capital Group
KNSL
$8.51B
| $49.7M | 0.08% |
148,364
-97,858
| -40% | -$36.3M |
|
116
MSCI
MSCI
$40.9B
| $49.6M | 0.08% |
87,732
-4,966
| -5% | -$2.56M |
|
117
Kadant
KAI
$3.99B
| $48.8M | 0.07% |
174,182
-16,320
| -9% | -$4.08M |
|
118
Columbia Sportswear
COLM
$2.94B
| $48.6M | 0.07% |
611,534
-12,510
| -2% | -$953K |
|
119
Cactus
WHD
$5.44B
| $48.5M | 0.07% |
1,067,535
-33,789
| -3% | -$1.54M |
|
|
CYBR
120
DELISTED
CyberArk
CYBR
| $48.3M | 0.07% |
220,408
+14,544
| +7% | +$2.7M |
|
121
ESCO Technologies
ESE
$7.92B
| $48.2M | 0.07% |
411,579
+63,498
| +18% | +$6.68M |
|
122
LivaNova
LIVN
$4.2B
| $48.1M | 0.07% |
930,556
+50,816
| +6% | +$2.46M |
|
123
Novanta
NOVT
$6.29B
| $48.1M | 0.07% |
285,807
-8,982
| -3% | -$1.31M |
|
|
SKX
124
DELISTED
Skechers
SKX
| $48M | 0.07% |
769,951
-58,040
| -7% | -$3.13M |
|
125
Supernus Pharmaceuticals
SUPN
$2.77B
| $47.4M | 0.07% |
1,636,490
-93,779
| -5% | -$2.49M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2023 Portfolio in Review
As of Q4 2023, Loomis, Sayles & Company held 1,073 positions worth $65.3B, up 12% from $58.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Loomis, Sayles & Company withdrew a net $1.98B in Q4 2023, closing 103 positions and reducing 511 holdings. Its most notable exit was Zions Bancorporation, an estimated $86.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Loomis, Sayles & Company opened a new position in Vertex worth $37.3M.
- Loomis, Sayles & Company's largest Q4 2023 buy was Vertex: 1,383,755 shares worth $37.3M.
- Loomis, Sayles & Company added most to O'Reilly Automotive in Q4 2023, an estimated $103M increase.
- Loomis, Sayles & Company's biggest Q4 2023 reduction was Bank of America Series L, cutting an estimated $766M.
- Loomis, Sayles & Company fully exited Zions Bancorporation in Q4 2023, selling an estimated $86.6M.
- Loomis, Sayles & Company's ten largest holdings make up 43% of its $65.3B portfolio in Q4 2023.
- Loomis, Sayles & Company opened 165 new positions and closed 103 in Q4 2023.
- Loomis, Sayles & Company's portfolio value rose 12% quarter-over-quarter to $65.3B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2023, filed 13 Feb 2024.